- Report
- October 2025
- 91 Pages
Middle East
From €4283EUR$4,850USD£3,699GBP
From €4283EUR$4,850USD£3,699GBP
- Report
- June 2025
- 92 Pages
Europe
From €3488EUR$3,950USD£3,013GBP
- Report
- June 2025
- 182 Pages
United States
From €5294EUR$5,995USD£4,573GBP
- Report
- May 2025
- 76 Pages
Middle East, Africa
From €2605EUR$2,950USD£2,250GBP
- Report
- May 2025
- 95 Pages
Asia Pacific
From €3047EUR$3,450USD£2,631GBP
- Report
- May 2025
- 98 Pages
Europe
From €3047EUR$3,450USD£2,631GBP
- Report
- May 2025
- 88 Pages
North America
From €2605EUR$2,950USD£2,250GBP
- Report
- March 2024
- 329 Pages
Global
From €5212EUR$6,109USD£4,350GBP
- Report
- July 2024
- 288 Pages
Global
From €5212EUR$6,109USD£4,350GBP
- Report
- October 2023
- 428 Pages
Global
From €5212EUR$6,109USD£4,350GBP
- Report
- November 2024
- 343 Pages
Global
From €4238EUR$4,799USD£3,660GBP
- Report
- September 2024
- 593 Pages
Global
From €4238EUR$4,799USD£3,660GBP
- Report
- January 2025
- 867 Pages
Global
From €4238EUR$4,799USD£3,660GBP
- Report
- January 2020
- 473 Pages
Global
From €4326EUR$4,899USD£3,737GBP
- Report
- October 2018
- 450 Pages
Global
From €3090EUR$3,499USD£2,669GBP
- Report
- July 2024
- 154 Pages
Global
From €3400EUR$3,850USD£2,937GBP
- Report
- November 2024
- 185 Pages
Global
From €3400EUR$3,850USD£2,937GBP
- Report
- January 2024
Global
From €4283EUR$4,850USD£3,699GBP
- Report
- December 2023
- 217 Pages
Global
From €4283EUR$4,850USD£3,699GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more